A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

PHASE3CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

Rocatinlimab

Subcutaneous (SC) injection

Trial Locations (77)

1121

Fundacion Cidea, Buenos Aires

1425

Instituto de Neumonologia y Dermatologia, Buenos Aires

2000

Centro de Investigaciones Clinicas Instituto Especialidades De La Salud De Rosario, Rosario

Fundacion Estudios Clinicos, Rosario

Instituto de Diagnostico ABC, Rosario

2010

The Skin Hospital, Darlinghurst

2065

Royal North Shore Hospital, St Leonards

2170

Liverpool Hospital, Liverpool

2217

Premier Specialists, Kogarah

2606

Woden Dermatology, Phillip

3132

Institute for Skin Health and Immunity, Mitcham

3168

Monash Childrens Hospital, Clayton

4102

Veracity Clinical Research, Woolloongabba

4217

The Skin Centre, Benowa

10029

Icahn School of Medicine at Mount Sinai, New York

11372

Smart Medical Research Inc, Jackson Heights

15355

Korea University Ansan Hospital, Ansansi, Gyeonggido

18249

DermDox Dermatology, LLC, Sugarloaf

33014

Palm Springs Community Health Center, Miami

Deluxe Health Care LLC, Miami Lakes

33176

ARA Professionals Limited Liability Corporation, Miami

34093

Bezmialem Vakif Universitesi Hastanesi, Istanbul

34098

Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul

34741

Manlio Dermatology, Kissimmee

35620

Bakircay Universitesi Cigli Egitim ve Arastirma Hastanesi, Izmir

38030

Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri

40509

Bluegrass Allergy Care, Lexington

45840

Auni Allergy, Findlay

55200

Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi, Samsun

72022

Dermatology Trial Associates, Bryant

72205

Little Rock Allergy and Asthma Clinical Research Center, Little Rock

75231

Modern Research Associates, Dallas

77004

Center for Clinical Studies, Houston

78411

Driscoll Childrens Hospital, Corpus Christi

84107

University of Utah MidValley Dermatology, Murray

85016

Phoenix Childrens Hosptial, Phoenix

85283

Medical Advancement Centers of Arizona, Tempe

90024

University of California Los Angeles, Los Angeles

90045

Dermatology Research Associates, Los Angeles

92697

University of California Irvine, Irvine

97201

Oregon Medical Research Center, Portland

08520

Windsor Dermatology dba Eczema Treatment Center of New Jersey, East Windsor

C1027AAP

Cinme - Centro de Investigaciones Metabolicas, CABA

80060-240

Universidade Federal do Parana, Curitiba

90160-093

Hospital Ernesto Dornelles, Porto Alegre

09060-870

Fundacao Abc - Centro Univ Fmabc, Santo André

12243-280

Ispem-Instituto São José dos Campos em Pesquisas Médicas, São José dos Campos

01308-050

Sociedade Beneficente de Senhoras Hospital Sirio Libanes, São Paulo

06454-010

Alergoalfa Nucleo Diagnostico Tratamento e Pesquisa Clinica em Alergia, São Paulo

T2J 7E1

Dermatology Research Institute Incorporated, Calgary

T5K 1X3

Stratica Dermatology, Edmonton

T6H 4J8

Vida Clinical Research, Edmonton

R3C 0N2

Winnipeg Clinic Dermatology Research, Winnipeg

A1E 1V4

Skincare Studio, St. John's

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Centre, Barrie

L7L 6W6

Halton Pediatric Allergy, Burlington

L8L 3C3

LEADER Research, Hamilton

L8S 1G5

Triple A Lab, Hamilton

K2C 3N2

JRB Research Incorporated, Ottawa

K9J 5K2

SKiN Centre for Dermatology, Peterborough

M3H 5Y8

Toronto Research Centre Inc, Toronto

M4E 1R7

FACET Dermatology, Toronto

Unknown

University of Hong Kong, Queen Mary Hospital, Hong Kong

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

04564

National Medical Center, Seoul

05278

Kyung Hee University Hospital at Gangdong, Seoul

06591

The Catholic University of Korea Seoul St Marys Hospital, Seoul

06973

Chung-Ang University Hospital, Seoul

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

07804

Ewha Womans University Seoul Hospital, Seoul

BS2 8BJ

Bristol Royal Hospital for Children, Bristol

HP11 2QW

Velocity Clinical Research, High Wycombe, High Wycombe

L12 2AP

Alder Hey Childrens Hospital, Liverpool

E11 1NR

Whipps Cross University Hospital, London

SE1 7EH

St Thomas Hospital, London

TR16 4ET

Carn to Coast Health Centres, Redruth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT05633355 - A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) | Biotech Hunter | Biotech Hunter